1,257
Views
0
CrossRef citations to date
0
Altmetric
Clinical focus: Cardiometabolic conditions- Editorial

Oral glucagon-like peptide-receptor agonists (GLP1RA) counseling: comparison with insulin counseling

, &
Pages 663-666 | Received 22 Jul 2020, Accepted 11 Aug 2020, Published online: 19 Oct 2020
 

Declaration of interest

The contents of the paper and the opinions expressed within are those of the authors, and it was the decision of the authors to submit the manuscript for publication.

Sanjay Kalra has received honoraria from Novo Nordisk, Eli Lilly, and Sanofi.

Atul Kalhan – There was no conflict of interest while this article was written, but they have received speaker fees and educational grants from Astra Zeneca, Boehringer Ingelheim, Novo Nordisk, Eli Lilly, Sanofi, NAPP, Takeda.

Reviewer disclosure

A reviewer on this manuscript has disclosed that they served as the first author for PIONEER 10. Peer reviewers on this manuscript have no other relevant financial relationships or otherwise to disclose.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.